University of Missouri officials have announced a $5 million grant agreement with the Wallace H. Coulter Foundation, through the Foundation’s Translational Partnership Award Program. The goal of the partnership is to develop technologies that will save, extend and improve patient lives and suffering from any disease or condition in any country around the world. The funds will be used to support collaborative projects between biomedical engineers and clinicians to take research discoveries to clinical practice.
“This is a major recognition of the University of Missouri and its researchers as only about 15 universities have been given this award,” said Jinglu Tan, James C. Dowell Professor and chair of biological engineering in the College of Engineering and the College of Agriculture, Food and Natural Resources. “This award will position us to become a national leader in translational biomedical research by building on existing successes in biomedical engineering research, cooperation between engineering and medicine researchers, and technology transfer projects. This award will allow our scientists to take their discoveries and develop them for use in the hospital or other clinical settings in an effort to improve the quality of life for many people.”
The agreement between MU and the Coulter Foundation stipulates that the Foundation will provide $666,667 per year for five years, while MU will match that money with $333,333 each year, for a total amount of $5 million over the next five years. An oversight committee, consisting of stake holders in translational research, will be formed to decide how to award the money to MU bioengineering faculty who are seeking to commercialize their research discoveries in partnership with clinicians.